Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 6 of 6 Results
All Results
No Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia (SOLARIS)
- Condition(s):
- Schizophrenia
- Status:
- Completed
- Requirements:
- 18 Years to 64 Years
- Interventions:
- Drug: TV-44749 | Drug: Placebo
A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia (SHINE)
- Condition(s):
- Schizophrenia
- Status:
- Completed
- Requirements:
- 13 Years to 65 Years
- Interventions:
- Drug: TV-46000 | Drug: Placebo
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia
- Condition(s):
- Schizophrenia
- Status:
- Completed
- Requirements:
- 18 Years to 64 Years
- Interventions:
- Drug: TV-44749
Real-World Impact of TV-44749 in Adults With Schizophrenia (RADIANCE)
- Condition(s):
- Schizophrenia
- Status:
- Not yet recruiting
- Requirements:
- 18 Years and older
- Interventions:
- Drug: TV-44749
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
- Condition(s):
- Schizophrenia
- Status:
- Completed
- Requirements:
- 18 Years to 64 Years
- Interventions:
- TV44749 | Oral Olanzapine
Study to Evaluate TV-46000 as Maintenance Treatment in Participants With Schizophrenia
- Condition(s):
- Schizophrenia
- Status:
- Completed
- Requirements:
- 13 Years to 65 Years
- Interventions:
- Drug: TV-46000 - A | Drug: TV-46000 - B | Drug: Placebo